These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19786508)

  • 1. A possible mechanism for the decrease in serum thyroxine level by a 2,3,7,8-tetrachlorodibenzo-p-dioxin-like polychlorinated biphenyl congener, 3,3',4,4',5-pentachlorobiphenyl in mice.
    Kato Y; Haraguchi K; Kubota M; Seto Y; Okura T; Ikushiro S; Koga N; Yamada S; Degawa M
    Drug Metab Dispos; 2010 Jan; 38(1):150-6. PubMed ID: 19786508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible mechanism for 2,2',4,4',5,5'-hexachlorobiphenyl-mediated decrease in serum thyroxine level in mice.
    Kato Y; Onishi M; Haraguchi K; Ikushiro S; Ohta C; Koga N; Endo T; Yamada S; Degawa M
    Toxicol Appl Pharmacol; 2011 Jul; 254(1):48-55. PubMed ID: 21569787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,3',4,4'-Tetrachlorobiphenyl-mediated decrease of serum thyroxine level in C57BL/6 and DBA/2 mice occurs mainly through enhanced accumulation of thyroxine in the liver.
    Kato Y; Haraguchi K; Onishi M; Ikushiro S; Endo T; Ohta C; Koga N; Yamada S; Degawa M
    Biol Pharm Bull; 2014; 37(3):504-9. PubMed ID: 24351552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible mechanism for 2,3',4,4',5'-pentachlorobiphenyl-mediated decrease in serum thyroxine level in mice.
    Kato Y; Onishi M; Haraguchi K; Ikushiro S; Ohta C; Koga N; Endo T; Yamada S; Degawa M
    Biol Pharm Bull; 2013; 36(10):1594-601. PubMed ID: 23877638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polychlorinated biphenyl-mediated decrease in serum thyroxine level in rodents.
    Kato Y; Haraguchi K; Ito Y; Fujii A; Yamazaki T; Endo T; Koga N; Yamada S; Degawa M
    Drug Metab Dispos; 2010 Apr; 38(4):697-704. PubMed ID: 20040582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Hydroxy-2,2',3,4',5,5',6-heptachlorobiphenyl-mediated decrease in serum thyroxine level in mice occurs through increase in accumulation of thyroxine in the liver.
    Kato Y; Haraguchi K; Kubota M; Seto Y; Ikushiro S; Sakaki T; Koga N; Yamada S; Degawa M
    Drug Metab Dispos; 2009 Oct; 37(10):2095-102. PubMed ID: 19589873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polychlorinated biphenyl congeners that increase the glucuronidation and biliary excretion of thyroxine are distinct from the congeners that enhance the serum disappearance of thyroxine.
    Martin LA; Wilson DT; Reuhl KR; Gallo MA; Klaassen CD
    Drug Metab Dispos; 2012 Mar; 40(3):588-95. PubMed ID: 22187485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mechanism for polychlorinated biphenyl-induced decrease in serum thyroxine level in rats.
    Kato Y; Ikushiro S; Takiguchi R; Haraguchi K; Koga N; Uchida S; Sakaki T; Yamada S; Kanno J; Degawa M
    Drug Metab Dispos; 2007 Oct; 35(10):1949-55. PubMed ID: 17639023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible mechanism for decrease in serum thyroxine level by polychlorinated biphenyls in Wistar and Gunn rats.
    Kato Y; Ikushiro S; Haraguchi K; Yamazaki T; Ito Y; Suzuki H; Kimura R; Yamada S; Inoue T; Degawa M
    Toxicol Sci; 2004 Oct; 81(2):309-15. PubMed ID: 15254343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice.
    Weber LW; Lebofsky M; Stahl BU; Smith S; Rozman KK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):155-62. PubMed ID: 7878671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic model of effects of dioxin on thyroid hormones in the rat.
    Kohn MC; Sewall CH; Lucier GW; Portier CJ
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):29-48. PubMed ID: 8560478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study on 2,2',4,5,5'-pentachlorobiphenyl-mediated decrease in serum thyroxine level between C57BL/6 and its transthyretin-deficient mice.
    Kato Y; Tamaki S; Haraguchi K; Ikushiro S; Sekimoto M; Ohta C; Endo T; Koga N; Yamada S; Degawa M
    Toxicol Appl Pharmacol; 2012 Sep; 263(3):323-9. PubMed ID: 22800508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative responsiveness of hypothyroxinemia and hepatic enzyme induction in Long-Evans rats versus C57BL/6J mice exposed to TCDD-like and phenobarbital-like polychlorinated biphenyl congeners.
    Craft ES; DeVito MJ; Crofton KM
    Toxicol Sci; 2002 Aug; 68(2):372-80. PubMed ID: 12151633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kanechlor 500-mediated changes in serum and hepatic thyroxine levels primarily occur in a transthyretin-unrelated manner.
    Kato Y; Tamaki S; Haraguchi K; Ikushiro SI; Fujii Y; Ohta C; Atobe K; Kimura O; Endo T; Koga N; Yamada S; Degawa M
    J Appl Toxicol; 2019 Dec; 39(12):1701-1709. PubMed ID: 31498458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated hepatotoxicity in C57BL/6J and DBA/2J mice.
    Shen ES; Gutman SI; Olson JR
    J Toxicol Environ Health; 1991 Apr; 32(4):367-81. PubMed ID: 2016751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
    Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.